Bioqual Inc BIOQ:OTCPK

RT Quote | Exchange | USD
Last | 05/09/22 EDT
78.00UNCH (UNCH)
52 week range
70.00 - 108.50
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close78.00
  • 52 Week High108.50
  • 52 Week High Date01/04/22
  • 52 Week Low70.00
  • 52 Week Low Date08/10/21

Key Stats

  • Market Cap69.42M
  • Shares Out890,000.00
  • 10 Day Average Volume0.00M
  • Dividend1.25
  • Dividend Yield1.60%
  • Beta-0.29
  • YTD % Change-25

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close78.00
  • 52 Week High108.50
  • 52 Week High Date01/04/22
  • 52 Week Low70.00
  • 52 Week Low Date08/10/21
  • Market Cap69.42M
  • Shares Out890,000.00
  • 10 Day Average Volume0.00M
  • Dividend1.25
  • Dividend Yield1.60%
  • Beta-0.29
  • YTD % Change-25

RATIOS/PROFITABILITY

  • EPS (TTM)6.14
  • P/E (TTM)12.69
  • Fwd P/E (NTM)-
  • EBITDA (TTM)9.058M
  • ROE (TTM)16.36%
  • Revenue (TTM)64.42M
  • Gross Margin (TTM)22.21%
  • Net Margin (TTM)8.53%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date09/25/2020
  • Div Amount1.10
  • Split Date-
  • Split Factor-

Latest On Bioqual Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Bioqual, Inc. is engaged in performing contract research services, which is primarily focused on animal models of human diseases, including acquired immune deficiency syndrome (AIDS), influenza, Respiratory Syncytial Virus (RSV) infection, Coronavirus infections (including COVID-19), Flavivirus infections (including Zika and Dengue), malaria, hepatitis, cancer, and other emerging infectious diseases. The Company also performs in vitro contract research services. It is...
Mark Lewis Ph.D.
Chairman of the Board, President, Chief Executive Officer
David Newcomer
Chief Financial Officer
Chander Sarma
Vice President - Facility Operations, Director - Information Technology
Address
9600 Medical Center Drive, Suite 101
Rockville, MD
20850-3336
United States